WELLS FARGO & COMPANY/MN
Position in ARQT — Arcutis Biotherapeutics, Inc.
CIK 72971
SAN FRANCISCO, CA
Position in ARQT
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$4,660,402
-$3,594,013 QoQ
Shares Held
197,810
-30.4% QoQ
Ownership
0.158%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.5905161518629.ToString("F0")%
Shared 0.ToString("F0")%
None 0.40948384813710126.ToString("F0")%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,293,431,965 across 386 Biotechnology names. ARQT ranks #31 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in ARQT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,660,402 | 197,810 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $8,254,415 | 284,243 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,984,093 | 105,257 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,752,125 | 196,300 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,102,334 | 198,359 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $730,697 | 52,455 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $332,688 | 35,773 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $340,053 | 36,565 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $275,081 | 27,758 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $69,812 | 21,614 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $460,790 | 86,778 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,017,326 | 106,750 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $688,985 | 62,635 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $50,910 | 3,440 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $73,802 | 3,862 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $78,121 | 3,666 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,672,034 | 138,735 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,935,994 | 141,562 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $18,472,081 | 773,214 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $24,505,653 | 897,972 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $25,359,574 | 876,584 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $18,100,416 | 643,456 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $16,301,435 | 556,363 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $15,940,320 | 527,127 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $12,330,375 | 413,771 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||